JPAG - serving its members since 1970
JPAG plans and delivers events that address all aspects of pharmaceutical analysis and related facets of medicine control & registration. NEXT EVENTS:
Thursday 11th May 2017The role of MS in impurity profilingRoyal Society of Chemistry, London
In association with the British Mass Spectrometry Society.
Impurities provide no benefit to patients; however, it is pragmatically accepted that complex, multi-stage pharmaceuticals cannot be manufactured without drug substance impurities or that drug products cannot be manufactured and stored without degradation products.
This symposium will explore the role of Mass Spectrometry (MS) in the identification and quantification of the various impurities that can be formed.
This symposium should be of interest to development, production, and academic scientists, as well as contract research organisations (CROs).
Dr Yaling Cheng - Pfizer
Dr Elspeth Gray - MHRA
Dr Sarah James - LGC
Dr Martin Ott - Lhasa
Dr Mark Perkins - Anatune
Dr Andrew Ray - AstraZeneca
Dr Mansoor Saeed - Syngenta
Dr Jean-Claude Wolff - GlaxoSmithKlineDETAILS AND BOOKING
Thursday 22nd June 2017Counterfeit medicinesRoyal Society of Chemistry, London
It is now widely accepted that counterfeiting is a huge and growing challenge of global proportion.
This symposium will take an overview of the problems authenticity must address from three different perspectives:
• The problem Globally
• The critical role of Discovery and Compliance
• The key role that authentic APIs play in Risk Management
each of which will be supported by relevant case studies.DETAILS AND BOOKING
EXTERNAL EVENT: Tuesday 5th September 2017JPAG at the APS 8th International PharmSci ConferenceDe Havilland Campus, University of Hertfordshire, Hatfield LAST EVENT:
To make a booking go to http://apsgb.orgDETAILS AND BOOKING
Thursday 16th March 2017Assuring data integrity; best practiceRoyal Society of Chemistry, London
Data integrity is receiving much attention in the pharmaceutical industry, with several high profile cases where deficiencies have resulted in regulatory action, and the MHRA, FDA, EMA and WHO have all issued guidance documents recently.
This symposium will bring together experts from Health Authorities, pharmaceutical companies, CROs and technology -providers to discuss the approaches being taken to rise to the challenge of increased scrutiny of data management practices.
Steven Brown - Novartis
Dr Adrian Davis - Pfizer Worldwide R&D
Dean Harris - Envigo Ltd
Tracy Moore - MHRA
Dr Gerhard Noelken - Data4Lab Ltd
Paul Smith - Agilent
Mark Stevens - Formpipe Life ScienceDETAILS
Follow and Like us on Social media
Delegates of any JPAG symposia can access the speakers presentations.
Just SIGN IN, go to RESOURCES and look in MY PAST MEETINGS.
Missed the meeting?
You can access a short report of recent meetings!
Just go to the MEETINGS page, go to PAST EVENTS. Then select the DETAILS for the meeting that interests you.
And do be sure to check the list of upcoming meetings so that you don't miss the next one!
European Pharmaceutical ReviewTESTIMONIALS:Excellent meeting, challenging and thought provoking. The organisation was excellent, thanks to all the efforts that JPAG team have made (March 2015)
JPAG members can receive a free hard copy subscription to EPRclick here
I have not attended a bad JPAG meeting yet. They are really good value for money and I really love to get the presentations as PDFs (June 2015)
ICH M9: BCS-based biowaivers
Here is the latest article in the series reproduced with permission from the European Pharmaceutical Review. It is entitled "ICH M9: BCS-based biowaivers", written by Dr Dave Elder, Chairman of the JPAG Committee. More...Monday 27th February 2017
Student Bursary Award
A JPAG Student Bursary Award was made to Riznam Ahmed, University College Cork, to provide travel funds to allow him to attend the symposium on Dissolution testing; current and future considerations
Mr Ahmed presented a poster on "Broa...More...Saturday 11th February 2017
More efficient management of post approval change control
Here is the latest article in the series reproduced with permission from the European Pharmaceutical Review. It is entitled "More efficient management of post approval change control", written by Dr Dave Elder, Chairman of the JPAG Committee. More...Sunday 18th December 2016
However, it does securely hold details for those who register an account.
This information is only used by JPAG as described in the Privacy Statement (see link on footer below).